medigraphic.com
ISSN 1405-1710 (Print)

2019, Number 1

<< Back Next >>

Rev Cent Dermatol Pascua 2019; 28 (1)

Inverted Psoriasis: diagnostic and therapeutic challenge

De Peña-Ortiz J, Maldonado-García CA, Villanueva-Otamendi A, González-González M, Gómez-Bernal NE, Ortiz-Lobato L

Language: Spanish
References: 17
Page: 11-14
PDF size: 251.76 Kb.


ABSTRACT

Psoriasis is considered an erythematosquamous dermatosis with great clinical polymorphism; it results from the shortening of the epidermal cell cycle associated with genetic and environmental factors. It occurs in 2% of the world population; the most common form (in 80-90% of the cases) is plaque or vulgar psoriasis. Inverted psoriasis has been reported in up to 24%, it affects folds (armpits, genitals, perineum, and the intergluteal, retroauricular, inframammary, and abdominal areas). It is characterized by erythematous plaques with few scales, given the humid environment of these regions. Therefore, it is necessary to perform a differential diagnosis with candidiasis, ringworm and intertrigo, to mention a few. Because of the clinical impact and quality of life, especially in those with genital lesions, it is necessary to start a treatment as soon as possible. The first line includes topical steroids, derivatives of vitamin D3 and calcineurin inhibitors. In this article we report a case of inverted psoriasis with characteristic clinical manifestations.


REFERENCES

  1. Rivas Bejarano JJ, Valdecantos WC. Psoriasis as autoinflammatory disease. Dermatol Clin. 2013; 31: 445-460.

  2. Wolff K, Goldsmith L, Katz S, Gilchrest B, Paller A, Leffell D. Fitzpatrick’s dermatology in general medicine. New York: McGraw Hill; 2008. pp. 169-197.

  3. Torres V, Camacho F, Mihm M, González S, Jurado F, Sánchez-Carpintero I. Dermatología práctica ibero-latinoamericana. México: Encuentros Científicos Académicos S.C.; 2012. 49: 1: 4923.

  4. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009; 361: 496-509.

  5. Daudén E, Castañeda S, Suárez C, García-Campayo J, Blasco AJ, Aguilar MD et al. Integrated approach to comorbidity in patients with psoriasis. Working Group on Psoriasis-Associated Comorbidities. Actas Dermosifiliogr. 2012; 103 Suppl 1: 1-64.

  6. Ammar M, Souissi-Bouchlaka C, Gati A, Zaraa I, Bouhaha R, Kouidhi S et al. Psoriasis: physiopathology and immunogenetics. Pathol Biol (Paris). 2014; 62: 10-23.

  7. Wilmer EN, Hatch RL. Resistant “candidal intertrigo”: could inverse psoriasis be the true culprit? J Am Board Fam Med. 2013; 26: 211-214.

  8. Elder DE, Elenitsas R, Johnson BL, Murphy GF. Lever’s histopathology of the skin. Philadelphia: Lippincott Williams & Wilkins; 2005. pp. 181-189.

  9. Navarrete G, Moreno LM, Mercadillo P, González M, Ramos JA. Programa de actualización continua. PAC Dermatología 3, Libro 4. Dermatopatología de dermatosis inflamatorias. Intersistemas Editores; 2010. pp. 184-185.

  10. Calanje E, Brenn T, Lazar A, McKee PH. McKee’s pathology of the skin: with clinical correlations. Elsevier; 2012. pp. 201-217.

  11. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009; 61: 451-485.

  12. Wozel G. Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas. Clin Dermatol. 2008; 26: 448-459.

  13. Kalb RE, Bagel J, Korman NJ, Lebwohl MG, Young M, Horn EJ et al. Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2009; 60: 120-124.

  14. Gribetz C, Ling M, Lebwohl M, Pariser D, Draelos Z, Gottlieb AB et al. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study. J Am Acad Dermatol. 2004; 51: 731-738.

  15. Lebwohl M, Freeman AK, Chapman MS, Feldman SR, Hartle JE, Henning A et al. Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol. 2004; 51: 723-730.

  16. Carrascosa JM, Vanaclocha F, Borrego L, Fernández-López E, Fuertes A, Rodríguez-Fernández-Freire L et al. Update of the topical treatment of psoriasis. Actas Dermosifiliogr. 2009; 100: 190-200.

  17. Zampetti A, Tiberi S. Inverse psoriasis. Clin Med (Lond). 2015; 15: 311.




2020     |     www.medigraphic.com